Samsung Biologics Co.,Ltd.
207940
Classifica tra le azioni
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Prezzo delle azioni
$1,028.49
Capitalizzazione di mercato
$47.88B
Variazione (1 giorno)
-3.67%
Variazione (1 anno)
-18.37%
Paese
KR
Scambia Samsung Biologics Co.,Ltd. (207940)
Categoria
Healthcare
Ricavi di Samsung Biologics Co.,Ltd. (207940)
Ricavi nel Sep 2026 TTM: $3.30B
Secondo gli ultimi rapporti finanziari di Samsung Biologics Co.,Ltd., i ricavi attuali dell'azienda (TTM) sono pari a $3.30B. Nel 2024, l'azienda ha registrato ricavi di $2.38B una diminuzione rispetto a i ricavi dell'anno 2023, che erano pari a $2.85B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Samsung Biologics Co.,Ltd. da 2014 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $3.30B | 4.55% |
| 2025 | $3.15B | 32.61% |
| 2024 | $2.38B | -16.65% |
| 2023 | $2.85B | 20.00% |
| 2022 | $2.38B | 80.33% |
| 2021 | $1.32B | 22.93% |
| 2020 | $1.07B | 76.59% |
| 2019 | $607.57M | 26.26% |
| 2018 | $481.19M | 10.37% |
| 2017 | $435.96M | 78.42% |
| 2016 | $244.35M | 214.60% |
| 2015 | $77.67M | -19.17% |
| 2014 | $96.09M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $12.62B | 282.80% |
US
|
|
| $2.23B | -32.44% |
US
|
|
| $15.74B | 377.41% |
AU
|
|
| $10.11B | 206.59% |
BE
|
|
| $6.02B | 82.58% |
NL
|
